Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue

被引:389
作者
Duan, DS
Sharma, P
Yang, JS
Yue, YP
Dudus, L
Zhang, YL
Fisher, KJ
Engelhardt, JF
机构
[1] Univ Iowa, Sch Med, Dept Anat & Cell Biol, Med Ctr, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Internal Med, Med Ctr, Iowa City, IA 52242 USA
关键词
D O I
10.1128/JVI.72.11.8568-8577.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Adeno-associated viral (AAV) vectors have demonstrated great utility for long-term gene expression in muscle tissue. However, the mechanisms by which recombinant AAV (rAAV) genomes persist in muscle tissue remain unclear. Using a recomibinant shuttle vector, we have demonstrated that circularized rAAV intermediates impart episomal persistence to rAAV genomes in muscle tissue. The majority of circular intermediates had a consistent head-to-tail configuration consisting of monomer genomes which slowly converted to large multimers of >12 kbp by 80 days postinfection. Importantly, long-term transgene expression was associated with prolonged (80-day) episomal persistence of these circular intermediates. Structural Features of these circular intermediates responsible for increased persistence included a DNA element encompassing two viral inverted terminal repeats (ITRs) in a head-to-tail orientation, which confers a 10-fold increase in the stability of DNA following incorporation into plasmid-based vectors and transfection into HeLa cells. These studies suggest that certain structural characteristics of AAV circular intermediates may explain long-term episomal persistence with this vector. Such information may also aid in the development of nonviral gene delivery systems with increased efficiency.
引用
收藏
页码:8568 / 8577
页数:10
相关论文
共 35 条
[1]   In vivo model of adeno-associated virus vector persistence and rescue [J].
Afione, SA ;
Conrad, CK ;
Kearns, WG ;
Chunduru, S ;
Adams, R ;
Reynolds, TC ;
Guggino, WB ;
Cutting, GR ;
Carter, BJ ;
Flotte, TR .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3235-3241
[2]   EXPRESSION FROM THE ADENO-ASSOCIATED VIRUS-P5 AND VIRUS-P19 PROMOTERS IS NEGATIVELY REGULATED IN TRANS BY THE REP PROTEIN [J].
BEATON, A ;
PALUMBO, P ;
BERNS, KI .
JOURNAL OF VIROLOGY, 1989, 63 (10) :4450-4454
[3]  
Bennett J, 1997, INVEST OPHTH VIS SCI, V38, P2857
[4]   INTEGRATION OF THE ADENO-ASSOCIATED VIRUS GENOME INTO CELLULAR DNA IN LATENTLY INFECTED HUMAN DETROIT-6 CELLS [J].
CHEUNG, AKM ;
HOGGAN, MD ;
HAUSWIRTH, WW ;
BERNS, KI .
JOURNAL OF VIROLOGY, 1980, 33 (02) :739-748
[5]   Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle [J].
Clark, KR ;
Sferra, TJ ;
Johnson, PR .
HUMAN GENE THERAPY, 1997, 8 (06) :659-669
[6]  
Conrad CK, 1996, GENE THER, V3, P658
[7]   Structural and functional heterogeneity of integrated recombinant AAV genomes [J].
Duan, DS ;
Fisher, KJ ;
Burda, JF ;
Engelhardt, JF .
VIRUS RESEARCH, 1997, 48 (01) :41-56
[8]   Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors [J].
Ferrari, FK ;
Samulski, T ;
Shenk, T ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3227-3234
[9]   Recombinant adeno-associated virus for muscle directed gene therapy [J].
Fisher, KJ ;
Jooss, K ;
Alston, J ;
Yang, YP ;
Haecker, SE ;
High, K ;
Pathak, R ;
Raper, SE ;
Wilson, JM .
NATURE MEDICINE, 1997, 3 (03) :306-312
[10]   Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis [J].
Fisher, KJ ;
Gao, GP ;
Weitzman, MD ;
DeMatteo, R ;
Burda, JF ;
Wilson, JM .
JOURNAL OF VIROLOGY, 1996, 70 (01) :520-532